PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pin-2(3)-ene | 201-291-9 | 80-56-8 | - | - | 3 | - | - | - | - | - | - | Details |
| pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate | 635-361-9 | 243973-20-8 | - | - | - | - | - | 1 | - | - | - | Details |
| Piperazine | 203-808-3 | 110-85-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Piperazine adipate | 205-569-0 | 142-88-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazine dihydrochloride | 205-551-2 | 142-64-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazine, compound with phosphoric acid | 217-775-8 | 1951-97-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazinium dihydrogen phosphate | 238-572-0 | 14538-56-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperidine | 203-813-0 | 110-89-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperidine, 1-methyl-, hydrochloride (1:1) | 605-832-3 | 17874-59-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperidinium chloride | 228-033-8 | 6091-44-7 | - | - | - | - | 1 | - | - | - | - | Details |